Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 4,800 shares, an increase of 1,500.0% from the February 28th total of 300 shares. Based on an average trading volume of 16,900 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s stock are sold short.

Integrated BioPharma Stock Performance

Shares of INBP remained flat at $0.34 during midday trading on Thursday. 25 shares of the stock traded hands, compared to its average volume of 19,815. The stock has a market cap of $10.30 million, a PE ratio of 11.34 and a beta of 0.89. The firm has a 50 day moving average price of $0.33 and a 200 day moving average price of $0.31. Integrated BioPharma has a one year low of $0.16 and a one year high of $0.42.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.